Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
Announced first patient dosed in the Phase 2b placebo-controlled portion of the…
Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements and Implementation of Cease Trade Order
August 08, 2025 18:28 ET Â | Source: Aja Health and Wellness Inc.…
NOTICE OF SETTLEMENT APPROVAL
DID YOU ACQUIRE SECURITIES OF TREVALI MINING CORPORATION BETWEEN OCTOBER 9, 2020…
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 16:55 ET Â | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British…
Rakovina Therapeutics Announces Stock Option Grants
July 29, 2025 17:00 ET Â | Source: Rakovina Therapeutics Inc VANCOUVER, British…
Cannabix Technologies Annual General and Special Meeting Results
July 24, 2025 21:06 ET Â | Source: Cannabix Technologies Inc. VANCOUVER, British…
Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
July 24, 2025 18:33 ET Â | Source: Aja Health and Wellness Inc.…
VERSES AI Inc. Announces Pricing of Public Offering of Units
July 09, 2025 09:08 ET Â | Source: VERSES AI Inc. VANCOUVER, British…
Treatment.com AI Grants Stock Option and RSUs
June 20, 2025 17:26 ET Â | Source: Treatment.com AI Inc. VANCOUVER, British…
VERSES Signs Soothsayer Analytics As First Genius Reseller and Fortune 500 Integrator
Agreement to accelerate global enterprise adoption of Genius through sales, training, certification,…